Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Mydecine Innovations Group Inc (OP: MYCOF ) 0.0076 +0.0001 (+1.33%) Streaming Delayed Price Updated: 2:26 PM EDT, Jun 11, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,654 Open 0.0052 Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 0.0075 Today's Range 0.0052 - 0.0111 52wk Range 0.0001 - 0.2308 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News InvestorNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Board Approves Issuance of Shares for Debt Settlement March 21, 2024 Via Investor Brand Network Mydecine Innovations Group Inc. Announces Share for Debt Settlement March 20, 2024 VANCOUVER, BC / TheNewswire / 20 March 2024 -- Mydecine Innovations Group Inc. (CSE: MYCO) (FSE: 0NFA), (OTC: MYCOF) (AQSE: MYIG) (the “Company” or “Mydecine”) announced that it has entered into a debt... Via TheNewswire.com Performance YTD -33.91% -33.91% 1 Month -60.21% -60.21% 3 Month -20.83% -20.83% 6 Month -91.98% -91.98% 1 Year -95.04% -95.04% More News Read More Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More February 15, 2024 Via Benzinga InvestorNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Compounds Receive USPTO Notice of Allowances February 08, 2024 Via Investor Brand Network Topics Artificial Intelligence Intellectual Property Exposures Artificial Intelligence Intellectual Property Product Safety InvestorNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Announces USPTO Issues Notice of Allowance for MYCO-005 Compound December 18, 2023 Via Investor Brand Network Topics Artificial Intelligence Intellectual Property Exposures Artificial Intelligence Intellectual Property Product Safety Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound December 18, 2023 From Mydecine Innovations Group Inc. Via GlobeNewswire InvestorNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Updates Special Access Program November 29, 2023 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Product Safety InvestorNewsBreaks – Mydecine Innovations Group Inc. (CSE: MYCO) (AQSE: MYIG) (OTC: MYCOF) Files Prospectus Supplement, Closes Share Subscription Agreements October 31, 2023 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Product Safety InvestorNewsBreaks – Mydecine Innovations Group Inc. (CSE: MYCO) (AQSE: MYIG) (OTC: MYCOF) Reports on Company Progress in Q4 2023 Update October 26, 2023 Via Investor Brand Network Exposures Product Safety Mydecine Provides Q4 2023 Business Update October 26, 2023 From Mydecine Innovations Group Inc. Via GlobeNewswire Mydecine Innovations Group gearing up for human trials after completing Aquis listing October 18, 2023 Via News Direct Mydecine Innovations Group gearing up for human trials after completing Aquis listing October 18, 2023 Via TheNewswire.com Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More October 16, 2023 Via Benzinga Exposures Product Safety Psychedelic-Based Drugs Biotech Company Begins Trading On UK's AQSE Growth Market October 12, 2023 Via Benzinga InvestorNewsBreaks – Mydecine Innovations Group Inc. (CSE: MYCO) (AQSE: MYIG) (OTC: MYCOF) Starts Trading on the AQSE Growth Market October 10, 2023 Via Investor Brand Network Topics Artificial Intelligence Intellectual Property Exposures Artificial Intelligence Intellectual Property Product Safety Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK and First Day of Dealings October 10, 2023 From Mydecine Innovations Group Inc. Via GlobeNewswire InvestorNewsBreaks – Mydecine Innovations Group Inc. (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) Common Shares Begin Listing on CSE October 06, 2023 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Product Safety InvestorNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Expects UK Dual Listing Admission Next Month September 28, 2023 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Product Safety InvestorNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Receives CSE Listing Conditional Approval August 31, 2023 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Product Safety Mydecine Announces Conditional Approval of CSE Listing August 30, 2023 From Mydecine Innovations Group Inc. Via GlobeNewswire Psyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly Reports August 21, 2023 Via Benzinga Topics Cannabis Economy Exposures Cannabis Interest Rates Mydecine Releases Q2 2023: Developer Of Smoke Cessation Psilocybin Prodrugs & MDMA Analogs August 15, 2023 Via Benzinga Jamaica Launches Organic Psilocybin Gummies & New Psychedelic Retreat: Rose Hill's New Offer August 01, 2023 Via Benzinga InvestorNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Announces Leadership Update July 24, 2023 Via Investor Brand Network InvestorNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Reports on Special Meeting July 06, 2023 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Product Safety Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
